New and Growing Nodules on Follow-Up LDCT Signal Higher Cancer Risk

Key Takeaways

• Stable pre-existing nodules showed the lowest malignancy association, new nodules were higher, and growing pre-existing nodules were highest.
• The analysis used the NLST LDCT arm with annual screens at T0, T1, and T2 and centered on nodules seen at T1.
• The authors described greater malignancy concern and closer follow-up attention when a follow-up CT shows a new or growing nodule.

The report assessed how nodules that were new or increased in size on follow-up LDCT related to malignancy risk, compared with pre-existing nodules that did not grow. It related follow-up imaging patterns to cancers attributed to specific nodules over the subsequent two years.

The central observation was that new nodules—and especially pre-existing nodules with interval growth—were associated with higher odds of malignancy than pre-existing nodules without growth.

The study described an analysis within the NLST low-dose CT arm, where participants underwent annual scans at T0, T1, and T2. Investigators focused the primary analysis on nodules identified at the first follow-up screen, T1, rather than baseline findings alone. The reported endpoint was lung cancer diagnosed within two years of the follow-up scan to which a specific nodule was linked. This design placed the T1 scan at the center of the timeline used to assess later cancer association.

Among nodules recorded at T1, researchers observed a gradient in cancer association across three categories defined by prior presence and interval change. Within two years, cancer was linked more often to new nodules and most strongly to pre-existing nodules with interval growth, while stable nodules had the lowest observed cancer linkage. Overall, the pattern showed a step-up in malignancy association from stable to new to growing nodules.

The comparative modeling aligned with this pattern. Regression analysis found that new nodules carried higher odds of a cancer diagnosis within two years than stable pre-existing nodules, with an odds ratio of 3.9 (95% CI: 2.51–6.05, p<0.0001). Pre-existing nodules with interval growth showed a stronger association, with an odds ratio of 19.7 (95% CI: 13.6–28.4, p<0.0001) relative to stable nodules. These risks were substantially greater than for most other well-established risk factors, as noted by the authors.

The authors characterized new nodules and interval enlargement on follow-up CT as findings that raised suspicion for malignancy and noted that malignancy frequency increased with nodule size. In their conclusion, they described more vigilant follow-up for new or growing nodules detected on subsequent scans than for nodules already present at baseline. Overall, change over time on follow-up imaging shaped the authors’ framing of malignancy risk.